Delivery Order SPE2DB22D2005-SPE2DB25FJLQ5
Award Date
4/28/25
Potential Completion Date
5/19/25
Potential Value
$40K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,044.00, is for the delivery of Xolair 150 mg/1.2 ml powder vials, a medication used to treat certain respiratory conditions. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 7, 2025. AmerisourceBergen Drug Corp holds a substantial...
This is a $34,576.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS, a specialty medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of March 24, 2025 and is not designated...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication XOLAIR 150 MG/1.2 ML POWDER VLS. The contract has a ceiling value of $20,022.00 and is a firm fixed-price, non-set-aside contract with a period of performance through May 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,644.08 firm fixed-price contract is for the delivery of XOLAIR 150 MG/ML syringes, a medication used to treat asthma and chronic hives. The contract has an ultimate completion date of May 12, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,440.40, is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a period of performance extending through May 20, 2025. This award is not associated with a set-aside program and represents open competition. Amerisourcebergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,881.36, is a delivery order for the medication XOLAIR 150 MG/ML SYRINGE. The contract is a firm fixed-price, non-set-aside award with a performance period through May 9, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,337.00, is a delivery order for XOLAIR 150 MG/1.2 ML POWDER VLS medical products. It is not designated as a set-aside contract. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML syringes, a medication used to treat certain medical conditions. The contract has a firm fixed price of $4,322.04 and a completion date of May 22, 2025. This contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,762.72, is a delivery order for the provision of XOLAIR 150 MG/ML SYRINGE medical products. The contract has a period of performance through May 22, 2025 and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This award is associated with a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,519.16, is for the delivery of the pharmaceutical product XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The contract is a firm fixed-price delivery order with a completion date of May 20, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for...